SPONSOR
4D Molecular Therapeutics
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Neovascular (Wet) Age-Related Macular DegenerationCystic Fibrosis LungFabry Disease
4D Molecular Therapeutics is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Neovascular (Wet) Age-Related Macular Degeneration, Cystic Fibrosis Lung, Fabry Disease.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — 4D Molecular Therapeutics
How many clinical trials has 4D Molecular Therapeutics sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by 4D Molecular Therapeutics, of which 3 are actively recruiting participants. These trials cover conditions including Neovascular (Wet) Age-Related Macular Degeneration, Cystic Fibrosis Lung, Fabry Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does 4D Molecular Therapeutics research focus on?
4D Molecular Therapeutics clinical trials span Neovascular (Wet) Age-Related Macular Degeneration, Cystic Fibrosis Lung, Fabry Disease. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a 4D Molecular Therapeutics clinical trial?
To participate in a 4D Molecular Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all 4D Molecular Therapeutics trials with current recruitment status updated daily.
Clinical Trials by 4D Molecular Therapeutics
NCT05197270 Phase 1, Phase 2
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
NCT05248230 Phase 2
Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
Cystic Fibrosis Lung
NCT05629559 Phase 1, Phase 2
Recruiting
4D-310 in Adults With Fabry Disease and Cardiac Involvement
Fabry Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology